Browse Technologies

Displaying 1 - 10 of 178


Human antibodies targeting a novel flu epitope for use as a universal flu vaccine and treatment

Scientists at Vanderbilt have discovered a new class of human antibodies specific to a novel target for the detection, prevention, and treatment of influenza A viruses (IAV). Using structural characterization, they have identified a novel antigenic site on the hemagglutin (HA) head domain that may be targeted by multiple antibodies simultaneously in a non-competitive manner. They found that administration of these antibodies against an otherwise lethal challenge with viruses of H1N1, H3N2, H5N1, or H7N9 subtypes confers protection when used as prophylaxis or therapy against major IAV subtypes that are pathogenic to humans. These antibodies may prove effective as a universal influenza treatment or in the design of a universal influenza vaccine.


Licensing Contact

Karen Rufus

615.322.4295

Inventors

James Crowe, Seth Zost

Steerable Needles: A Better Turning Radius with Less Tissue Damage

A team of Vanderbilt engineers and surgeons have developed a new steerable needle that can make needle based biopsy and therapy delivery more accurate. A novel flexure-based tip design provides enhanced steerability while simultaneously minimizing tissue damage. The present device is useful for almost any needle-based procedure including biopsy, thermal ablation, brachytherapy, and drug delivery.


Licensing Contact

Chris Harris

615.343.4433

Fused in Sarcoma (FUS) Nuclear Translocation Inhibitors for Preventing Fibrosis

The research team has found that one of the key regulators of collagen production in fibrotic diseases is the FUS ribonucleoprotein. This protein is upregulated in fibrotic diseases leading to additional collagen formation and deposition. In order to combat FUS upregulation, a new approach to blocking nuclear translocation has been developed using an FUS targeting peptide approach.


Licensing Contact

Mike Villalobos

615.322.6751
Therapeutics

Non-Invasive Skin Cancer Detection using Raman Spectroscopy-OCT System (Portfolio)

Vanderbilt University researchers have designed a system for non-invasive discrimination between normal and cancerous skin lesions. The system combines the depth-resolving capabilities of OCT technique with Raman Spectroscopy's specificity of molecular chemistry. By linking both imagining techniques into a single detector arm, the complexity, cost, and size of previously reported RS-OCT instruments have been significantly improved. The combined instrument is capable of acquiring data sets that allow for more thorough assessment of a sample than existing optical techniques.


Licensing Contact

Masood Machingal

615.343.3548

Adaptive PCR: A PCR control system to overcome challenging conditions

A PCR control system to overcome challenging conditions. By directly monitoring the hybridization of fluorescently labelled L-DNA mimics of the template DNA strands and primers, it is possible to improve the efficiency of PCR in challenging conditions. This approach eliminates some of the sample preparation and trial and error that would otherwise be required for difficult sample types such as urine or other samples that contain high levels of salts.  In addition, this approach enables on-demand PCR in most any environment.


Licensing Contact

Karen Rufus

615.322.4295
Research Reagent

MAESTRO: Non-Robotic Dexterous Laparoscopic Instrument with a Wrist providing seven degrees of freedom

Inventors at Vanderbilt University have developed a non-robotic dexterous laparoscopic manipulator with a wrist providing seven-degrees-of-freedom. The device has a novel user interface that intuitively maps motion of the surgeon's hands to the tool's "hands".


Licensing Contact

Chris Harris

615.343.4433
Medical Devices

Prevention of Cytokine Induced Apoptosis In Intestinal Epithelial Cells By A Probiotic Bacterium

The present invention provides therapeutic and prophylactic compositions for use in treating and preventing disorders involved epithelial cell apoptosis, such as gastrointestinal disorders (e.g., inflammatory bowel disease, Crohn's disease or ulcerative colitis) in a subject, such as a human patient.


Licensing Contact

Mike Villalobos

615.322.6751

Inventors

Brent Polk, Fang Yan
Therapeutics
Gastrointestinal
Protein/Peptide

Gratings on Porous Silicon Structures for Sensing Applications

In this technology diffraction-based sensors made from porous materials are used for the detection of small molecules. The porous nature of the diffraction gratings that gives rise to an extremely large active sensing area enables a very high level of sensitivity. Specificity is achieved by functionalizing the porous gratings with selective binding species.


Licensing Contact

Virinchi Juttukonda

615.343.2430

Continuum Robots with Equilibrium Modulation (CREM)

The A.R.M.A. Laboratory of Vanderbilt University has developed a novel continuum robot design enabling multi-scale motion at the macro and micro scale. The unique design allows miniaturization with minimal added cost thereby potentially giving rise to a new generation of surgical robots capable of both macro-motion for surgical intervention and micro-scale motion for cellular-level imaging or intervention. Micro-motion is achieved through a unique method for altering the equilibrium pose of the robot via material re-distribution throughout the length of the robot. This process ushers in a new class of surgical robotics termed continuum robots with equilibrium modulation (CREM).


Licensing Contact

Masood Machingal

615.343.3548
Medical Devices

Transoral Lung Access Device

Transoral lung access is preferable to traditional needlebasedaccess due to the lower risk of lung collapse. However present bronchoscope-based devices enable access to only a small portion of the lung. The present device is a robotic image-guided bronchoscope to navigate the airway under closed-loop control to the target. IT is designed to provide transoral access to any location in the lung, particularly the hard-to-reach peripheral regions.


Licensing Contact

Chris Harris

615.343.4433
Medical Devices